Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

103.65
BATS BZX Real-Time Price
As of 10:15am ET
 -1.75 / -1.66%
Today’s Change
47.03
Today|||52-Week Range
111.49
+6.86%
Year-to-Date

Today’s Trading

Previous close105.40
Today’s open106.00
Day’s range103.11 - 106.00
Volume27,677
Average volume (3 months)718,475
Market cap$8.8B
Dividend yield--
Data as of 10:00am ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+37.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.69

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.23-0.35%
ISISIsis Pharmaceuticals...-0.28-0.42%
ICLRICON PLC-1.29-1.86%
CRLCharles River Labora...-1.26-1.64%
Data as of 10:15am ET, 03/03/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account